Latest News Archive
Please select Category, Year, and then Month to display items
17 August 2020
|
Story Nitha Ramnath
|
Photo istock
Within the next five years, 60% of the world’s population will be living in urban areas. Urban living comes with large-scale economic advantages and society benefits from economies of scale. But, COVID-19 is challenging urban living. We have introduced the term ‘social distancing’ and some policy analysts have even argued for the de-densification of cities.
Join us for a discussion where our panellists will analyse this perceived conflict.
Date: Thursday, 27 August 2020
Time: 14:00 to 15:30 (South African Standard Time – GMT +2)
Please RSVP to Elelwani Mmbadi at
mmbadiE@ufs.ac.za no later than 25 August, upon which you will receive a Skype for Business meeting invite and link to access the webinar.
Speakers:
Prof Ivan Turok
Dr Geci Karuri-Sebina
Mr Thiresh Govender
Moderator:
Lochner Marais
UFS Doctors make History in South Africa
2011-07-14
|
|
| New aortic valve |
Three members of our Faculty of Health Sciences made history by being the first to implant a special new aortic valve in South Africa.
In a combined effort, the Departments of Cardiology, Pediatric Cardiology and Cardiothoracic Surgery did the first Medtronic CoreValve implant in South Africa on a patient in Universitas Academic Hospital.
With the support of hospital management and the Medtronic company, Prof. Hennie Theron, Prof. Stephen Brown and Dr JP Theron of the Faculty of Health Sciences, with the assistance of Dr Jean-Claude Laborde, performed the operation early on Wednesday morning, 06 July 2011.
The advantage of this new valve is that it can be implanted percutaneously through a catheter from the groin. This eliminates the need for invasive surgery.
The valve is made from porcine pericardium (tissue derived from pigs) and is mounted on an expandable stent, which is threaded along an artery, until it reaches its desired position. Prof. Theron says the valve is especially useful in older patients who suffer from aortic valve disease and pose a high surgical risk. Furthermore, the use of this valve greatly reduces hospitalisation time, in comparison to traditional surgery.
“One patient already received an implant this morning and we hope to finish 2 more today,” Prof. Brown said, emphasizing the swiftness and efficiency of the new valve implanting process.
“It is a complex procedure, but this service can in future be offered to all patients in the public and private sectors of the Free State. It is heartwarming that the academic complex can take the lead in this modern, high-tech therapy.”
For more information on the procedure, please contact Prof. Theron at 051 4053428.